Deepak Nitrite Ltd. Share Price

Overview

Deepak Nitrite Ltd. share price is currently ₹1,593.70, up by ₹31.27 (2%) from its previous closing price of ₹1,562.43. The share price has declined -1.84% over the past month and declined -11.94% over the past year. The stock's 52-week low and high are ₹1,268.57 and ₹1,881.20, respectively. Deepak Nitrite Ltd. has a market capitalisation of ₹ 22,105.22 Cr. The share price was last updated on 09 Oct 2026, 03:29 PM IST.

Deepak Nitrite Ltd.
Deepak Nitrite Ltd.
DEEPAKNTR
 ₹0.00
 ₹31.27
2.00%
Chemicals
 ₹0.00(%)1D

Updated: 09 Oct 2026, 03:29:53 pm IST

Market Data

Open Price

 ₹1,554.87

Prev. Close

 ₹1,562.43
 ₹1,554.87

Day Low

 ₹1,607.56

Day High

 ₹1,268.57

52 Week Low

 ₹1,881.20

52 Week High

ChemicalsChemicals
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

27.76

Sector PE

28.64

PB Ratio

3.72

Sector PB

4.09

EPS

57.42

Dividend Yield

0.58

Today's Volume

370.992 K

5 Day Avg. Volume

302.032 K

PEG Ratio

-1.32

Market Cap.

₹ 22,105.22 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 375% at ₹7.5/Share
27-Jul-202627-Jul-2026
DividendsFinal Dividend of 375% at ₹7.5/Share
04-Aug-202504-Aug-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
Kotak Mid Cap Fund - Regular Plan - Growth40.79 Lac
40.79 Lac
no change
Nippon India Small Cap Fund - Growth18.58 Lac
18.58 Lac
no change
Franklin India Small Cap Fund - Growth13.88 Lac
16.38 Lac
(18.01%)
Franklin India Mid Cap Fund - Growth11.00 Lac
11.00 Lac
no change
SBI Multi Asset Allocation Fund - Regular Plan - Growth5.00 Lac
10.00 Lac
(100%)

About Deepak Nitrite Ltd. 👋

Deepak Nitrite Limited is an India-based company, which is engaged in manufacturing and trading of chemicals. The Company operates through two segments: Advanced Intermediates and Phenolics. Its Advanced Intermediates segment offers Nitrites, Nitro Toluidines, Fuel Additives, Xylidines, Oximes, Cumidines, Speciality Agrochemicals, Optical Brightening Agent (OBA), diamino stilbene disulfonic acid (DASDA), and Benzotrifluoride. Its Phenolics segment offers cumene, phenol, acetone, isopropyl alcohol, and ammonium sulfate (AMS). The Company's products cater to several industries, such as paints, pharma, health care, colorants, rubber chemicals, explosives, dyes, pigments, food colors, pharmaceuticals, refineries, agrochemicals, glass, personal care, paper, detergents, and textiles. Its manufacturing facilities are located at Nandesari and Dahej (Gujarat); Roha and Taloja (Maharashtra); and Hyderabad (Telangana).

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
AASHISH RA

AASHISH RA

8 Oct • 11:41 AM · SEBI-Registered Analyst

Basic Chemicals, Advanced Intermediates, Fine .

DEEPAKNTR
Strengths - Strong integrated business model: backward and forward integration helps control raw materials, improve supply reliability and capture more value. GoDeepak - Strong market position in products such as sodium nitrite/nitrate, phenol, acetone and IPA. - Among the top three global players in products such as xylidines, cumidines and oximes. GoDeepak opportunity. - Strong R&D, manufacturing capabilities and more than five decades of operating experience. Weaknesses - Advanced Intermediates remains vulnerable to global oversupply and pricing pressure in certain products. - Chemical businesses are sensitive to raw-material, energy and international pricing cycles. - Large expansion projects increase capital expenditure and execution requirements. - Phenolics is a relatively high-volume business where margins can fluctuate with benzene/cumene and phenol-acetone spreads. Opportunities - China+1 / supply-chain diversification can benefit Indian specialty-chemical manufacturers as global customers diversify sourcing. GoDeepak - Large downstream expansion into polycarbonate resins could materially increase value addition. - DCTL has approved investments of about ₹5,000 Cr for an integrated polycarbonate-resin facility, with additional upstream investments of ₹3,500 Cr in phenol, acetone and IPA. 54th Annual Integrated Report - Growth in pharmaceuticals, agrochemicals, electronics, EVs, mobility and high-performance materials. Threats - Chinese competition and global chemical oversupply can create sustained pricing pressure. - Crude/benzene and other raw-material price volatility. - Environmental and chemical-safety regulations. - Project delays or cost overruns in large expansion programmes. - Global economic slowdown can reduce demand from pharma, agrochemical, automotive and industrial customers. - Currency and international trade-policy risks.

See More
Umang Bhutada

Umang Bhutada

1 Oct • 12:28 AM · SEBI-Registered Analyst

Deepak Nitrite commissions ₹300 crore chemicals plant

Deepak Nitrite Limited (

DEEPAKNTR
) has commissioned manufacturing operations at its Chlorination & Specialty Chemicals facility in Gujarat through its subsidiary Deepak Chem Tech. The company has incurred approximately ₹300 crore of capex on the project. Your view The key development is commercial commissioning rather than just a capex announcement. The new facility expands Deepak Nitrite's specialty-chemicals manufacturing footprint. The next numbers I would watch are utilisation, product volumes, margins and the pace at which the new capacity contributes to consolidated earnings. The project also needs to be evaluated against the company's overall capital expenditure and return on capital. Disclosure: I do not hold any position or have any interest in Deepak Nitrite Limited as of the time of posting.

See More
Dhwani Patel

Dhwani Patel

16 Sep • 8:22 AM · SEBI-Registered Analyst

Deepak Nitrite Tests a Major Long-Term Support

DEEPAKNTR
is tied closely to the specialty and intermediate chemicals cycle, where margins can swing sharply with global demand, feedstock prices, capacity additions and downstream utilization. The long-term opportunity around import substitution and higher-value chemical manufacturing remains relevant, but the monthly chart shows that the stock is still working through a major corrective phase after the extraordinary rerating seen between 2017 and 2021. Price is near ₹1,561 and is trading below the monthly Ichimoku conversion line near ₹1,589, while the base line around ₹2,225 remains far above current price. The cloud ahead is also positioned above the stock, which keeps the broader trend under pressure. What makes the current area important is that ₹1,500–1,560 is close to the lower end of the multi-year consolidation that has developed since 2022. A decisive break below this region would weaken the long-term structure further, while holding it could allow another base-building attempt. On the upside, ₹1,590 is the first hurdle, but the chart would need to reclaim the ₹1,900–2,200 zone before the larger trend can be considered repaired.

See More
DEEPAK PAL

DEEPAK PAL

28 Aug • 12:30 PM · SEBI-Registered Analyst

“क्या है Golden Crossover Strategy? कमाएगी या फंसाएगी?”

अगर आप Technical Analysis सीख रहे हैं, तो आपने Golden Crossover का नाम जरूर सुना होगा। यह एक ऐसा technical signal है जिसे traders अक्सर long-term bullish trend की शुरुआत के संकेत के रूप में देखते हैं। लेकिन Golden Crossover आखिर होता क्या है? ----->Golden Crossover क्या होता है? जब किसी stock या index की short-term moving average, उसकी long-term moving average को ऊपर की तरफ cross करती है, तो इसे Golden Crossover कहा जाता है। सबसे popular combination है: 50-Day Moving Average > 200-Day Moving Average यानी जब: 50 DMA, 200 DMA को नीचे से ऊपर cross करे तो इसे Golden Crossover कहा जाता है। ##इसे Bullish Signal क्यों माना जाता है? 50 DMA short-term price trend को दिखाता है। 200 DMA long-term trend को दिखाता है। जब 50 DMA, 200 DMA के ऊपर चला जाता है, तो इसका मतलब है कि: Short-Term Momentum ↑ और Long-Term Trend मजबूत होने लगा है इसलिए traders इसे संभावित trend reversal या new uptrend का संकेत मानते हैं। ------>Golden Crossover के 3 Important Stages Stage 1 — Downtrend Price कमजोर होता है और short-term average long-term average के नीचे रहता है। Stage 2 — Recovery Price में buying शुरू होती है और 50 DMA तेजी से ऊपर आने लगता है। Stage 3 — Golden Crossover 50 DMA, 200 DMA को ऊपर की तरफ cross करता है। यहीं से traders bullish trend की संभावना पर ध्यान देना शुरू करते हैं। ##SOME STOCKS WITH GOLDEN CROSSOVER STRATEGY SOLARA JYOTICNC

PERSISTENT
DEEPAKNTR BLACKBUCK ##Bottom Line याद रखें: Golden Cross trend को confirm कर सकता है, लेकिन future की guarantee नहीं देता। यही कारण है कि इसे “Bullish Signal” समझें, “Guaranteed Buy Signal” नहीं।

See More
Stock Reader

Stock Reader

16 Aug • 2:39 PM · SEBI-Registered Analyst

Deepak Nitrite continues to stand out as one of India’s strongest specialty chemical and performance materials companies

DEEPAKNTR
The key bullish trigger is the company’s increasing focus on value-added and downstream products, which can structurally improve margins and reduce dependence on commodity-like businesses. Its expansion across advanced intermediates, phenolics and performance materials provides multiple avenues for long-term growth. India’s China+1 opportunity remains an important structural tailwind. Global customers are actively diversifying supply chains, and established Indian manufacturers with scale, technical capabilities and reliable execution are well positioned to capture incremental demand. Another important factor is Deepak Nitrite’s capital expenditure cycle. Successful commissioning and ramp-up of new capacities could translate into meaningful revenue growth and operating leverage over the coming years. As utilization improves, incremental revenue can potentially contribute disproportionately to EBITDA. The company also benefits from a strong balance sheet and an established customer base, giving it the financial flexibility to pursue future growth opportunities while maintaining a relatively conservative risk profile. From a long-term perspective, the thesis is not simply about near-term earnings—it is about Deepak Nitrite moving further up the chemical value chain and increasing the proportion of higher-margin products in its portfolio. Key factors to monitor include capacity ramp-up, margins, execution of capex, raw-material prices and global chemical demand. Overall view: Bullish for the long term, provided execution remains strong and new capacities scale as expected.

See More
Pradeep Carpenter

Pradeep Carpenter

7 Aug • 8:52 AM · SEBI-Registered Analyst

Morning Market Insights | 7 August 2026

Indian equity markets are expected to open on a steady note as the broader trend remains positive despite the recent consolidation. Nifty continues to form a pattern of higher highs and higher lows on the daily chart, indicating that the underlying bullish structure is intact. Sector rotation has also been healthy, with leadership shifting across sectors, suggesting sustained market participation. Traders may continue to adopt a "buy on dips" strategy as long as the index holds above key support levels. Technically, Nifty has immediate support at 24,350–24,420. Holding above this zone could keep the momentum intact and pave the way for a move towards 24,700–24,750, which remains the immediate resistance zone for the day. A decisive breakout above this range may extend the ongoing uptrend. Bank Nifty also remains in a strong technical setup after registering consecutive closes above the crucial 57,500 resistance level. The index is likely to witness buying interest near 57,600–57,650, while immediate resistance is placed at 58,200–58,250. A sustained move above these levels could open the doors for 58,500 and higher. Stocks in Focus Positive Triggers Premier Energies: Plans to raise ₹5,000 crore through a Qualified Institutional Placement (QIP). Allied Blenders: Board approves capacity expansion at the Moradabad facility.

DEEPAKNTR
: Subsidiary commissions a new manufacturing plant. Prataap Snacks, Apollo Pipes: Promoters increase stake, reflecting confidence in business prospects. Indegene: Quant Mutual Fund acquires nearly 95 lakh shares. Negative Triggers
ALKEM
: US FDA classifies its Daman facility as Official Action Indicated (OAI) following seven observations.
DABUR
: US FDA issues a warning letter for its Silvassa manufacturing facility.

See More

News & Events

Frequently Asked Questions

What is the share price of Deepak Nitrite Ltd.?

What is the market cap of Deepak Nitrite Ltd.?

Should I buy Deepak Nitrite Ltd. stock now?

What is the 52 week high and low of Deepak Nitrite Ltd.?

Is the Deepak Nitrite Ltd. stock good to buy?

Is Deepak Nitrite Ltd. a good buy for the long term?

Is Deepak Nitrite Ltd. overvalued or undervalued?

What is the PE and PB ratio of Deepak Nitrite Ltd.?

Start Now